A dominant negative H-ras mutant, N116Y, was transfected into a variet
y of human tumor cell lines. N116Y extremely inhibited the proliferati
on of A431 (vulva), PC3 (prostate), T24 (bladder), MCF7 (breast), NKPS
and TMK1 (stomach) cancer cell lines. A431 and PC3 cells were particu
larly susceptible to N116Y. In order to examine the effects of N116Y o
n the neoplastic phenotypes, we transfected a less efficient N116Y exp
ression vector into A431 cells. Almost all clones survived after G418
selection. However, they did not retain the N116Y gene and only one cl
one faintly expressed N116Y. this N116Y-expressing clone had not tumor
igenicity in vivo, and revealed deformed morphology and DNA fragmentat
ion, suggesting that N116Y might have induced apoptotic cell death. Th
us, N116Y may be applicable for gene therapy of a wide spectrum of hum
an tumors.